<VariationArchive VariationID="405440" VariationName="NM_004287.5(GOSR2):c.22dup (p.Thr8fs)" VariationType="Duplication" Accession="VCV000405440" Version="11" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-29" DateCreated="2017-04-17" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="402756" VariationID="405440">
      <GeneList>
        <Gene Symbol="GOSR2" FullName="golgi SNAP receptor complex member 2" GeneID="9570" HGNC_ID="HGNC:4431" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="46923160" stop="46975890" display_start="46923160" display_stop="46975890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45000485" stop="45018732" display_start="45000485" display_stop="45018732" Strand="+" />
          </Location>
          <OMIM>604027</OMIM>
        </Gene>
        <Gene Symbol="LRRC37A2" FullName="leucine rich repeat containing 37 member A2" GeneID="474170" HGNC_ID="HGNC:32404" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.31-21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="46372792" stop="47049128" display_start="46372792" display_stop="47049128" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_167251.2" start="195713" stop="378581" display_start="195713" display_stop="378581" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NT_187663.1" start="1032151" stop="1075353" display_start="1032151" display_stop="1075353" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="44590075" stop="44633013" display_start="44590075" display_stop="44633013" Strand="+" />
          </Location>
          <OMIM>616556</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004287.5(GOSR2):c.22dup (p.Thr8fs)</Name>
      <CanonicalSPDI>NC_000017.11:46923211:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="46923211" stop="46923212" display_start="46923211" display_stop="46923212" variantLength="1" positionVCF="46923211" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45000577" stop="45000578" display_start="45000577" display_stop="45000578" variantLength="1" positionVCF="45000577" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <OtherNameList>
        <Name>p.Thr8Asnfs*54</Name>
      </OtherNameList>
      <ProteinChange>T8fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.45000580dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.45000580dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.46923214dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.46923214dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031806.2" sequenceAccession="NG_031806" sequenceVersion="2" change="g.5095dup">
            <Expression>NG_031806.2:g.5095dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012511.3" sequenceAccession="NM_001012511" sequenceVersion="3" change="c.22dup">
            <Expression>NM_001012511.3:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012529.1" sequenceAccession="NP_001012529" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001012529.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321133.2" sequenceAccession="NM_001321133" sequenceVersion="2" change="c.22dup">
            <Expression>NM_001321133.2:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308062.1" sequenceAccession="NP_001308062" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001308062.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321134.2" sequenceAccession="NM_001321134" sequenceVersion="2" change="c.-81dup">
            <Expression>NM_001321134.2:c.-81dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330252.2" sequenceAccession="NM_001330252" sequenceVersion="2" change="c.22dup">
            <Expression>NM_001330252.2:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317181.1" sequenceAccession="NP_001317181" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001317181.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353114.2" sequenceAccession="NM_001353114" sequenceVersion="2" change="c.22dup">
            <Expression>NM_001353114.2:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340043.1" sequenceAccession="NP_001340043" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001340043.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353115.2" sequenceAccession="NM_001353115" sequenceVersion="2" change="c.22dup">
            <Expression>NM_001353115.2:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340044.1" sequenceAccession="NP_001340044" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001340044.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353116.2" sequenceAccession="NM_001353116" sequenceVersion="2" change="c.22dup">
            <Expression>NM_001353116.2:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340045.1" sequenceAccession="NP_001340045" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001340045.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363851.2" sequenceAccession="NM_001363851" sequenceVersion="2" change="c.-444dup">
            <Expression>NM_001363851.2:c.-444dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004287.5" sequenceAccession="NM_004287" sequenceVersion="5" change="c.22dup" MANESelect="true">
            <Expression>NM_004287.5:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004278.2" sequenceAccession="NP_004278" sequenceVersion="2" change="p.Thr8fs">
            <Expression>NP_004278.2:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_054022.4" sequenceAccession="NM_054022" sequenceVersion="4" change="c.22dup">
            <Expression>NM_054022.4:c.22dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_473363.1" sequenceAccession="NP_473363" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_473363.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148349.2" sequenceAccession="NR_148349" sequenceVersion="2" change="n.55dup">
            <Expression>NR_148349.2:n.55dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148350.2" sequenceAccession="NR_148350" sequenceVersion="2" change="n.55dup">
            <Expression>NR_148350.2:n.55dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148351.2" sequenceAccession="NR_148351" sequenceVersion="2" change="n.55dup">
            <Expression>NR_148351.2:n.55dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004287.4" sequenceAccession="NM_004287" sequenceVersion="4" change="c.22dupA">
            <Expression>NM_004287.4:c.22dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004287.4" sequenceAccession="NM_004287" sequenceVersion="4" change="c.22dup">
            <Expression>NM_004287.4:c.22dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8621102" DB="ClinGen" />
        <XRef Type="rs" ID="746855352" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND Progressive myoclonic epilepsy" Accession="RCV000468851" Version="5">
        <ClassifiedConditionList TraitSetID="13597">
          <ClassifiedCondition DB="MedGen" ID="C0751778">Progressive myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND Muscular dystrophy" Accession="RCV000509134" Version="1">
        <ClassifiedConditionList TraitSetID="20201">
          <ClassifiedCondition DB="MedGen" ID="C0026850">Muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND Inborn genetic diseases" Accession="RCV002429479" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-06-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND not provided" Accession="RCV003128943" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-16" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004287.5(GOSR2):c.22dup (p.Thr8fs) AND GOSR2-related disorder" Accession="RCV003960021" Version="2">
        <ClassifiedConditionList TraitSetID="94733">
          <ClassifiedCondition>GOSR2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-27" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-27" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2017-04-17" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(4); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">21549339</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(4); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-03-14">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-03-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-10-23">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-10-23">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20201" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="14907" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy</ElementValue>
                <XRef ID="Muscular+dystrophy/4983" DB="Genetic Alliance" />
                <XRef ID="MONDO:0020121" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7922" />
                <XRef ID="7922" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98473" DB="Orphanet" />
              <XRef ID="C0026850" DB="MedGen" />
              <XRef ID="D009136" DB="MeSH" />
              <XRef ID="MONDO:0020121" DB="MONDO" />
              <XRef Type="primary" ID="HP:0003560" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003544" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003806" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="94733" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="74176" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GOSR2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GOSR2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOSR2-Related Disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="13597" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial progressive myoclonic epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive myoclonus epilepsy</ElementValue>
                <XRef ID="MONDO:0020074" DB="MONDO" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy</ElementValue>
                <XRef ID="Progressive+myoclonic+epilepsy/9622" DB="Genetic Alliance" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic Epilepsies, Progressive</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7140" />
                <XRef ID="7140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng217</URL>
                <CitationText>UK NICE Guideline NG217, Epilepsies in children, young people and adults, 2022</CitationText>
              </Citation>
              <XRef ID="308" DB="Orphanet" />
              <XRef ID="98261" DB="Orphanet" />
              <XRef ID="C0751778" DB="MedGen" />
              <XRef ID="MONDO:0020074" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1174201" SubmissionDate="2017-08-22" DateLastUpdated="2017-10-16" DateCreated="2017-10-16">
        <ClinVarSubmissionID localKey="genomeconnect_16113_623" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000607039" DateUpdated="2017-10-16" DateCreated="2017-10-16" Type="SCV" Version="1" SubmitterName="GenomeConnect, ClinGen" OrgID="506185" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment Type="public">GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Purpose>validation</Purpose>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome Sequencing</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2016-07-18">Cincinnati Children's Hospital Medical Center</Attribute>
                <Comment Type="public">Likely pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2017-03-17" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Short stature</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Failure to thrive</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Generalized hypotonia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001290" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the pelvis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001469" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the thorax</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0009131" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the musculature of the limbs</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0009127" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of muscle morphology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011805" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of muscle physiology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0011804" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001321133.1:c.22dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0026850" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GenomeConnect_hg19_81817</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7111212" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="GDXSV:260747" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003805937" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="17" alternateAllele="A" referenceAllele="-" start="45000580" stop="45000581" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4131516</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_166_20230301054205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1056588" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="438727|MedGen:C0751778" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000543669" DateUpdated="2024-02-14" DateCreated="2017-04-17" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21549339</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr8Asnfs*54) in the GOSR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GOSR2 are known to be pathogenic (PMID: 21549339). This variant is present in population databases (rs746855352, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with GOSR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 405440). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.45000577_45000578insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751778" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5218491" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a850829|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002731743" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.22dupA mutation, located in coding exon 1 of the GOSR2 gene, results from a duplication of A at nucleotide position 22, causing a translational frameshift with a predicted alternate stop codon (p.T8Nfs*54). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004287.3:c.22dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7354446" SubmissionDate="2023-06-21" DateLastUpdated="2023-06-24" DateCreated="2023-06-24">
        <ClinVarSubmissionID localKey="NM_004287.4:c.22dupA|GOSR2-Related Disorders" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003933746" DateUpdated="2023-06-24" DateCreated="2023-06-24" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: GOSR2 c.22dupA (p.Thr8AsnfsX54) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Variants downstream of this position have been classified as pathogenic in ClinVar. The variant allele was found at a frequency of 3.2e-05 in 154034 control chromosomes. To our knowledge, no occurrence of c.22dupA in individuals affected with GOSR2-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic (n=2) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004287.4:c.22dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GOSR2-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13562035</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7896065" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1537229|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004224212" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PM2, PM3, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004287.4:exon 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Thr8Asnfs*54</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004287.4:c.22dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8851620" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3939829|GOSR2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004771344" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The GOSR2 c.22dupA variant is predicted to result in a frameshift and premature protein termination (p.Thr8Asnfs*54). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0081% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant occurs in the gene's first coding exon, upstream of all previously reported disease-associated GOSR2 variants. An alternative in-frame start codon is present less than 20 amino acids downstream in exon 2. Although we suspect this variant may be pathogenic, at this time, the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GOSR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004287.4:c.22dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GOSR2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8851620" TraitType="Disease" MappingType="Name" MappingValue="GOSR2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="GOSR2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Generalized hypotonia" MappingRef="Preferred">
        <MedGen CUI="C1858120" Name="Generalized hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the musculature of the thorax" MappingRef="Preferred">
        <MedGen CUI="C4024580" Name="Abnormality of the musculature of the thorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7111212" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7354446" TraitType="Disease" MappingType="Name" MappingValue="GOSR2-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="GOSR2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7896065" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the musculature of the limbs" MappingRef="Preferred">
        <MedGen CUI="C4024582" Name="Abnormality of the musculature of the limbs" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Disease" MappingType="XRef" MappingValue="C0026850" MappingRef="MedGen">
        <MedGen CUI="C0026850" Name="Muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5218491" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of muscle physiology" MappingRef="Preferred">
        <MedGen CUI="C4023182" Name="Abnormal muscle physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Failure to thrive" MappingRef="Preferred">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1056588" TraitType="Disease" MappingType="XRef" MappingValue="C0751778" MappingRef="MedGen">
        <MedGen CUI="C0751778" Name="Progressive myoclonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174201" TraitType="Finding" MappingType="Name" MappingValue="Short stature" MappingRef="Preferred">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

